Eliem Therapeutics Stock News

Eliem Therapeutics Inc (ELYM) shares closed today 11.8% lower than it did at the end of yesterday. The stock is currently down 21.3% year-to-date, down 21.3% over the past 12 months, and down 21.3% over the past five years. Today, the Dow Jones Industrial Average rose 1.0%, and the S&P 500 rose 1.4%. Trading Activity Shares traded as high as $14.98 and as low as $9.22 this week.Shares closed 57.9% below its 52-week high and 53.3% above its 52-week low.Trading volume this week was 94.6% higher than the 10-day average and 157.4% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Eliem Therapeutics Inc (ELYM) shares closed today 31.0% higher than it did at the end of yesterday. The stock is currently down 10.8% year-to-date, down 10.8% over the past 12 months, and down 10.8% over the past five years. Today, the Dow Jones Industrial Average rose 0.6%, and the S&P 500 rose 0.6%. Trading Activity Shares traded as high as $14.52 and as low as $8.82 this week.Shares closed 52.2% below its 52-week high and 73.9% above its 52-week low.Trading volume this week was 39.5% lower than the 10-day average and 14.0% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Eliem Therapeutics Inc (ELYM) shares closed today 31.0% higher than it did at the end of yesterday. The stock is currently down 31.9% year-to-date, down 31.9% over the past 12 months, and down 31.9% over the past five years. Today, the Dow Jones Industrial Average rose 0.6%, and the S&P 500 rose 0.6%. Trading Activity Shares traded as high as $14.52 and as low as $8.82 this week.Shares closed 52.2% below its 52-week high and 73.9% above its 52-week low.Trading volume this week was 23.9% lower than the 10-day average and 9.0% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Eliem Therapeutics Inc (NASDAQ:ELYM)s stock price fell 3.8% on Wednesday . The stock traded as low as $11.25 and last traded at $11.33. 14,834 shares traded hands during trading, a decline of 89% from the average session volume of 141,003 shares. The stock had previously closed at $11.78. Several research firms have recently weighed in []

On track to advance two clinical programs through five proof-of-concept trials and progress two preclinical programs over the next 18-24 months

The summer IPO market is wrapping up, and while we could see a few more launches, this past week's two deals should be some of the last IPOs before fall. SPAC activity continued to bounce back, with 1

SEATTLE and CAMBRIDGE, United Kingdom, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (NASDAQ: ELYM), a clinical-stage biotechnology company focused on developing novel therapies for neuro

SEATTLE and CAMBRIDGE, United Kingdom, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc., a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitabilit

Eliem Therapeutics Aims For $81 Million U.S. IPO